Hims & Hers Health (HIMS 24.28%) stock took a rather predictable hit Monday morning. Down 25 percent. It happens. So it goes.
They’d announced plans to sell a pill version of Wegovy, for forty-nine dollars. A clever price. Novo Nordisk (NVO +3.36%) makes the original, of course. One hundred forty-nine for the pill, one hundred ninety-nine for the injection. Capitalism, you know? A perfectly reasonable system, if you ignore the suffering.
Novo wasn’t pleased. Lawsuits were threatened. Then the FDA weighed in. They don’t much care for copycats, apparently. Or maybe they just like being asked nicely. They suggested Hims & Hers might lose access to the ingredients they needed. Or worse. Products seized. It’s a big country. Lots of rules.
By Saturday, Hims & Hers surrendered. They wouldn’t sell the pill. It was the sensible thing to do, really. Though, of course, it wasn’t about sense. It was about power. And money. Always money.
Hims & Hers blinked. Novo didn’t even flinch.
Here’s what happened: Hims & Hers gambled. They thought they could get away with copying Novo’s weight loss drug, ride on Novo’s advertising, and undercut the price. A beautiful plan, in a way. If it had worked, it would have been a victory for… someone. Probably consumers. But that rarely happens.
It didn’t work. So it goes.
Novo sued. They want a permanent ban, not just on Hims’ pill, but on any compounded versions of their drugs. A rather sweeping request. A bit like asking for the moon. But they have lawyers. And money. Lots of it.
What this means for the stock, and for us.
Novo’s lawsuit is about a patent. The ‘343 Patent, to be precise. It covers semaglutide, and anything containing it. If Novo wins, Hims & Hers won’t be able to make any GLP-1 weight loss drugs using semaglutide. A rather large problem, if you happen to be Hims & Hers.
They may have lost their GLP-1 business. It’s a shame, of course. But these things happen. A small tragedy, in the grand scheme of things. A reminder that even the cleverest schemes can fail. And that sometimes, the biggest companies win, simply because they can afford to. So it goes.
Read More
- 21 Movies Filmed in Real Abandoned Locations
- 2025 Crypto Wallets: Secure, Smart, and Surprisingly Simple!
- The 11 Elden Ring: Nightreign DLC features that would surprise and delight the biggest FromSoftware fans
- 10 Hulu Originals You’re Missing Out On
- The 10 Most Beautiful Women in the World for 2026, According to the Golden Ratio
- 🚨 Kiyosaki’s Doomsday Dance: Bitcoin, Bubbles, and the End of Fake Money? 🚨
- Crypto’s Comeback? $5.5B Sell-Off Fails to Dampen Enthusiasm!
- 39th Developer Notes: 2.5th Anniversary Update
- Gold Rate Forecast
- Top ETFs for Now: A Portfolio Manager’s Wry Take
2026-02-09 19:42